abstract |
The invention relates to an antibody that binds using the first binding domain to the type I Fc epsilon receptor (FcRI) and using the second binding domain to the Fc gamma receptor IIB (FcRIIB). The invention also relates to a nucleic acid sequence encoding an antibody, a vector containing at least one of the nucleic acid sequences, a host cell transfected with a nucleic acid sequence or vector, a pharmaceutical composition comprising, as an active ingredient, an antibody, nucleic acid, vector or cell - the host, as well as the use of antibodies for the treatment or prevention of allergies to pollen. |